Biopharmaceutical innovation has significantly increased life expectancy in Europe, with Antibiotice Iași in Romania being a pioneer since 1955. Today, the company is a leading producer of generic medicines in the EU, aiming to meet the global demand for improved healthcare. The EIB provided a €25 million loan and comprehensive advisory support to Antibiotice to expand its production site and boost research and development.
